A Guide to Laboratory Biosafety Levels

The American Biological Safety Association (ABSA) sets the standard for biosafety levels and laboratory requirements in the United States. To mitigate the risk of infection and contamination from pathogenic microorganisms, the ABSA has developed four distinct biosafety levels that, when properly implemented, should contain harmful biological agents and prevent contamination. What Biosafety Level Should My […]

After SLAS2018: The Next Generation of Scientists

SLAS is one of those events that always leaves us reflective and inspired on our return trip home. This year, our chief scientist, Ben Tjoa, and I represented Astarte Biologics in San Diego. We met amazing scientists, had meaningful conversations, and heard from world leaders. SLAS2018 set a new attendance record — over 6,600 attendees […]

Everything You Need to Prepare Tissue Samples in One Kit

If your New Year’s resolution is to be more efficient in the lab, we’ve got exactly what you need to stick to your promises. Introducing our Tissue Digestion Kit! Our newest assay kit contains the key materials you need to prepare 10 tissue samples, including optimized assay buffer, instructions, and expected results. The only things […]

Gene Therapy News: FDA Approves First In Vivo Treatment

In 2017, we witnessed gene therapy breakthroughs up to the very end. In the final weeks of the year, the first in vivo gene therapy, Luxturna, was approved by the FDA. Luxturna is intended to improve sight for patients with rare forms of inherited vision loss. Luxturna is administered through a one-time injection into a […]

Ask A Scientist: What’s the Difference Between Primary and Immortalized Cells?

While most researchers today prefer primary cells for immunology, inflammation, and vaccination experiments due to the close match to in vivo function, immortalized cell lines still have advantages and preferred use cases. Let’s take a closer look at the differences between the two cell types. Understanding the Difference Primary cells are isolated directly from a […]

Anti-SIRPα Antibodies: A Promising Avenue for Immunotherapy

Conventional cancer therapies such as chemotherapy and radiation have a significant downfall: while targeting cancerous tumors, they also damage healthy cells which can lead to undesirable patient side-effects. Despite high expectations at the onset, treatments using monoclonal antibodies have historically faced limitations. While attempting to discover why monoclonal antibodies were not performing as expected, researchers […]

Thank You for a Great 2017!

It’s hard to believe 2017 is coming to a close in just a few short days. What a year it has been! There have been many groundbreaking immunotherapy innovations this year. From the first-ever FDA-approved CAR-T cell therapy to the federal PACT initiative investing $215 million in immunotherapy research to countless other advancements, it’s incredible […]

New Evidence of Oxidative Burst in Neutrophils

Neutrophils are known for the oxidative burst released during phagocytosis, which demonstrates the intracellular killing mechanism that is key to the function of the immune system. Until now, we were not able to demonstrate this oxidative burst in our cryopreserved neutrophil products even though we knew they were capable of phagocytosis. Improved Isolation Methods Our […]